| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |